Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$56K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| Jan 5 | BCYC | Bicycle Therapeutics PLC | SSELL◷ | 1,878 | $6.54 | $12.3K | -2.1% | Open the original filing on SEC.gov |
| Jan 5 | BCYC | Bicycle Therapeutics PLC | SSELL◷ | 2,456 | $6.45 | $15.8K | -2.7% | Open the original filing on SEC.gov |
| Jan 2 | PTCT | Ptc Therapeutics, INC. | AGRANT◆ | 3,475 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | PTCT | Ptc Therapeutics, INC. | AGRANT | 4,000 | — | — | +23.4% | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT◷◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | SSELL◷ | 3,289 | $6.80 | $22.4K | -3.5% | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT◷ | 50,000 | — | — | +111.9% | Open the original filing on SEC.gov |
| Oct 2, 2025 | BCYC | Bicycle Therapeutics PLC | SSELL◷ | 265 | $8.61 | $2.3K | -0.6% | Open the original filing on SEC.gov |
| Oct 2, 2025 | BCYC | Bicycle Therapeutics PLC | SSELL◷ | 217 | $8.40 | $1.8K | -0.5% | Open the original filing on SEC.gov |
| Jul 2, 2025 | BCYC | Bicycle Therapeutics PLC | SSELL | 204 | $7.09 | $1.4K | -0.4% | Open the original filing on SEC.gov |
| Jun 11, 2025 | PCRX | Pacira BioSciences, Inc. | AGRANT◆ | 11,279 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | PCRX | Pacira BioSciences, Inc. | AGRANT | 6,163 | — | — | +117.8% | Open the original filing on SEC.gov |